Resverlogix listed under Other Promising Drugs to fight Covid -19
The New York Times maintains a broad tracker of COVID-19 treatments under development, as does the Milken Institute on their treatment and vaccine tracker.
RESVERLOGIX
APABETALONE (RVX-208), SELECTIVE BET (BROMODOMAIN AND EXTRA-TERMINAL) INHIBITOR
Funder: Unknown
Clinical Trials For Other Diseases; Treat various conditions
Clinical Trials for Covid -19 NCTO4894266
https://www.treatearly.org/promising-drugs
Koo